The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Blood Vessels Embolic Agents Market Research Report 2025
Synopsis
Playing a more vital role in the field of medicine than ever before, embolotherapy is a type of endovascular treatment that aims to occlude abnormal blood vessels in order to control bleeding, close fistulae or arteriovenous malformations, devascularise organs, reduce tumours and much more. This report focus on Blood Vessels Embolic Agents market.
The global Blood Vessels Embolic Agents market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Blood Vessels Embolic Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Vessels Embolic Agents.
Report Scope
The Blood Vessels Embolic Agents market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Blood Vessels Embolic Agents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Blood Vessels Embolic Agents companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Boston Scientific Corporation
Cook Medical LLC
Johnson & Johnson
Medtronic
Acandis GmbH
SSEM Mthembu Medical (Pty) Ltd
Balt USA LLC
Stryker
Guerbet LLC
Terumo Corporation
Penumbra
Grandpharma (Sirtex)
Merit Medical
Siemens Healthineers (Varian)
Jiangsu Hengrui Medicine
Kaneka
Meril Life Sciences
Peijia Medical
Wallaby Medical
MicroPort Scientific Corporation
Weihai Visee Medical Devices
Beijing Taijieweiye Technology
Segment by Type
Microsphere
Liquid Embolics Agents
Embolic Coils
Embolic Plug Systems
Detachable Balloons
Others
Segment by Application
Hospital & Clinic
Ambulatory Surgical Center
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Blood Vessels Embolic Agents companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Playing a more vital role in the field of medicine than ever before, embolotherapy is a type of endovascular treatment that aims to occlude abnormal blood vessels in order to control bleeding, close fistulae or arteriovenous malformations, devascularise organs, reduce tumours and much more. This report focus on Blood Vessels Embolic Agents market.
The global Blood Vessels Embolic Agents market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Blood Vessels Embolic Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Vessels Embolic Agents.
Report Scope
The Blood Vessels Embolic Agents market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Blood Vessels Embolic Agents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Blood Vessels Embolic Agents companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Boston Scientific Corporation
Cook Medical LLC
Johnson & Johnson
Medtronic
Acandis GmbH
SSEM Mthembu Medical (Pty) Ltd
Balt USA LLC
Stryker
Guerbet LLC
Terumo Corporation
Penumbra
Grandpharma (Sirtex)
Merit Medical
Siemens Healthineers (Varian)
Jiangsu Hengrui Medicine
Kaneka
Meril Life Sciences
Peijia Medical
Wallaby Medical
MicroPort Scientific Corporation
Weihai Visee Medical Devices
Beijing Taijieweiye Technology
Segment by Type
Microsphere
Liquid Embolics Agents
Embolic Coils
Embolic Plug Systems
Detachable Balloons
Others
Segment by Application
Hospital & Clinic
Ambulatory Surgical Center
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Blood Vessels Embolic Agents companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Blood Vessels Embolic Agents Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Microsphere
1.2.3 Liquid Embolics Agents
1.2.4 Embolic Coils
1.2.5 Embolic Plug Systems
1.2.6 Detachable Balloons
1.2.7 Others
1.3 Market by Application
1.3.1 Global Blood Vessels Embolic Agents Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital & Clinic
1.3.3 Ambulatory Surgical Center
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Blood Vessels Embolic Agents Market Perspective (2019-2030)
2.2 Blood Vessels Embolic Agents Growth Trends by Region
2.2.1 Global Blood Vessels Embolic Agents Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Blood Vessels Embolic Agents Historic Market Size by Region (2019-2024)
2.2.3 Blood Vessels Embolic Agents Forecasted Market Size by Region (2025-2030)
2.3 Blood Vessels Embolic Agents Market Dynamics
2.3.1 Blood Vessels Embolic Agents Industry Trends
2.3.2 Blood Vessels Embolic Agents Market Drivers
2.3.3 Blood Vessels Embolic Agents Market Challenges
2.3.4 Blood Vessels Embolic Agents Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Blood Vessels Embolic Agents Players by Revenue
3.1.1 Global Top Blood Vessels Embolic Agents Players by Revenue (2019-2024)
3.1.2 Global Blood Vessels Embolic Agents Revenue Market Share by Players (2019-2024)
3.2 Global Blood Vessels Embolic Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Blood Vessels Embolic Agents Revenue
3.4 Global Blood Vessels Embolic Agents Market Concentration Ratio
3.4.1 Global Blood Vessels Embolic Agents Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Blood Vessels Embolic Agents Revenue in 2023
3.5 Blood Vessels Embolic Agents Key Players Head office and Area Served
3.6 Key Players Blood Vessels Embolic Agents Product Solution and Service
3.7 Date of Enter into Blood Vessels Embolic Agents Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Blood Vessels Embolic Agents Breakdown Data by Type
4.1 Global Blood Vessels Embolic Agents Historic Market Size by Type (2019-2024)
4.2 Global Blood Vessels Embolic Agents Forecasted Market Size by Type (2025-2030)
5 Blood Vessels Embolic Agents Breakdown Data by Application
5.1 Global Blood Vessels Embolic Agents Historic Market Size by Application (2019-2024)
5.2 Global Blood Vessels Embolic Agents Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Blood Vessels Embolic Agents Market Size (2019-2030)
6.2 North America Blood Vessels Embolic Agents Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Blood Vessels Embolic Agents Market Size by Country (2019-2024)
6.4 North America Blood Vessels Embolic Agents Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Blood Vessels Embolic Agents Market Size (2019-2030)
7.2 Europe Blood Vessels Embolic Agents Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Blood Vessels Embolic Agents Market Size by Country (2019-2024)
7.4 Europe Blood Vessels Embolic Agents Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Blood Vessels Embolic Agents Market Size (2019-2030)
8.2 Asia-Pacific Blood Vessels Embolic Agents Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Blood Vessels Embolic Agents Market Size by Region (2019-2024)
8.4 Asia-Pacific Blood Vessels Embolic Agents Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Blood Vessels Embolic Agents Market Size (2019-2030)
9.2 Latin America Blood Vessels Embolic Agents Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Blood Vessels Embolic Agents Market Size by Country (2019-2024)
9.4 Latin America Blood Vessels Embolic Agents Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Blood Vessels Embolic Agents Market Size (2019-2030)
10.2 Middle East & Africa Blood Vessels Embolic Agents Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Blood Vessels Embolic Agents Market Size by Country (2019-2024)
10.4 Middle East & Africa Blood Vessels Embolic Agents Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Blood Vessels Embolic Agents Introduction
11.1.4 Abbott Revenue in Blood Vessels Embolic Agents Business (2019-2024)
11.1.5 Abbott Recent Development
11.2 Boston Scientific Corporation
11.2.1 Boston Scientific Corporation Company Detail
11.2.2 Boston Scientific Corporation Business Overview
11.2.3 Boston Scientific Corporation Blood Vessels Embolic Agents Introduction
11.2.4 Boston Scientific Corporation Revenue in Blood Vessels Embolic Agents Business (2019-2024)
11.2.5 Boston Scientific Corporation Recent Development
11.3 Cook Medical LLC
11.3.1 Cook Medical LLC Company Detail
11.3.2 Cook Medical LLC Business Overview
11.3.3 Cook Medical LLC Blood Vessels Embolic Agents Introduction
11.3.4 Cook Medical LLC Revenue in Blood Vessels Embolic Agents Business (2019-2024)
11.3.5 Cook Medical LLC Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Blood Vessels Embolic Agents Introduction
11.4.4 Johnson & Johnson Revenue in Blood Vessels Embolic Agents Business (2019-2024)
11.4.5 Johnson & Johnson Recent Development
11.5 Medtronic
11.5.1 Medtronic Company Detail
11.5.2 Medtronic Business Overview
11.5.3 Medtronic Blood Vessels Embolic Agents Introduction
11.5.4 Medtronic Revenue in Blood Vessels Embolic Agents Business (2019-2024)
11.5.5 Medtronic Recent Development
11.6 Acandis GmbH
11.6.1 Acandis GmbH Company Detail
11.6.2 Acandis GmbH Business Overview
11.6.3 Acandis GmbH Blood Vessels Embolic Agents Introduction
11.6.4 Acandis GmbH Revenue in Blood Vessels Embolic Agents Business (2019-2024)
11.6.5 Acandis GmbH Recent Development
11.7 SSEM Mthembu Medical (Pty) Ltd
11.7.1 SSEM Mthembu Medical (Pty) Ltd Company Detail
11.7.2 SSEM Mthembu Medical (Pty) Ltd Business Overview
11.7.3 SSEM Mthembu Medical (Pty) Ltd Blood Vessels Embolic Agents Introduction
11.7.4 SSEM Mthembu Medical (Pty) Ltd Revenue in Blood Vessels Embolic Agents Business (2019-2024)
11.7.5 SSEM Mthembu Medical (Pty) Ltd Recent Development
11.8 Balt USA LLC
11.8.1 Balt USA LLC Company Detail
11.8.2 Balt USA LLC Business Overview
11.8.3 Balt USA LLC Blood Vessels Embolic Agents Introduction
11.8.4 Balt USA LLC Revenue in Blood Vessels Embolic Agents Business (2019-2024)
11.8.5 Balt USA LLC Recent Development
11.9 Stryker
11.9.1 Stryker Company Detail
11.9.2 Stryker Business Overview
11.9.3 Stryker Blood Vessels Embolic Agents Introduction
11.9.4 Stryker Revenue in Blood Vessels Embolic Agents Business (2019-2024)
11.9.5 Stryker Recent Development
11.10 Guerbet LLC
11.10.1 Guerbet LLC Company Detail
11.10.2 Guerbet LLC Business Overview
11.10.3 Guerbet LLC Blood Vessels Embolic Agents Introduction
11.10.4 Guerbet LLC Revenue in Blood Vessels Embolic Agents Business (2019-2024)
11.10.5 Guerbet LLC Recent Development
11.11 Terumo Corporation
11.11.1 Terumo Corporation Company Detail
11.11.2 Terumo Corporation Business Overview
11.11.3 Terumo Corporation Blood Vessels Embolic Agents Introduction
11.11.4 Terumo Corporation Revenue in Blood Vessels Embolic Agents Business (2019-2024)
11.11.5 Terumo Corporation Recent Development
11.12 Penumbra
11.12.1 Penumbra Company Detail
11.12.2 Penumbra Business Overview
11.12.3 Penumbra Blood Vessels Embolic Agents Introduction
11.12.4 Penumbra Revenue in Blood Vessels Embolic Agents Business (2019-2024)
11.12.5 Penumbra Recent Development
11.13 Grandpharma (Sirtex)
11.13.1 Grandpharma (Sirtex) Company Detail
11.13.2 Grandpharma (Sirtex) Business Overview
11.13.3 Grandpharma (Sirtex) Blood Vessels Embolic Agents Introduction
11.13.4 Grandpharma (Sirtex) Revenue in Blood Vessels Embolic Agents Business (2019-2024)
11.13.5 Grandpharma (Sirtex) Recent Development
11.14 Merit Medical
11.14.1 Merit Medical Company Detail
11.14.2 Merit Medical Business Overview
11.14.3 Merit Medical Blood Vessels Embolic Agents Introduction
11.14.4 Merit Medical Revenue in Blood Vessels Embolic Agents Business (2019-2024)
11.14.5 Merit Medical Recent Development
11.15 Siemens Healthineers (Varian)
11.15.1 Siemens Healthineers (Varian) Company Detail
11.15.2 Siemens Healthineers (Varian) Business Overview
11.15.3 Siemens Healthineers (Varian) Blood Vessels Embolic Agents Introduction
11.15.4 Siemens Healthineers (Varian) Revenue in Blood Vessels Embolic Agents Business (2019-2024)
11.15.5 Siemens Healthineers (Varian) Recent Development
11.16 Jiangsu Hengrui Medicine
11.16.1 Jiangsu Hengrui Medicine Company Detail
11.16.2 Jiangsu Hengrui Medicine Business Overview
11.16.3 Jiangsu Hengrui Medicine Blood Vessels Embolic Agents Introduction
11.16.4 Jiangsu Hengrui Medicine Revenue in Blood Vessels Embolic Agents Business (2019-2024)
11.16.5 Jiangsu Hengrui Medicine Recent Development
11.17 Kaneka
11.17.1 Kaneka Company Detail
11.17.2 Kaneka Business Overview
11.17.3 Kaneka Blood Vessels Embolic Agents Introduction
11.17.4 Kaneka Revenue in Blood Vessels Embolic Agents Business (2019-2024)
11.17.5 Kaneka Recent Development
11.18 Meril Life Sciences
11.18.1 Meril Life Sciences Company Detail
11.18.2 Meril Life Sciences Business Overview
11.18.3 Meril Life Sciences Blood Vessels Embolic Agents Introduction
11.18.4 Meril Life Sciences Revenue in Blood Vessels Embolic Agents Business (2019-2024)
11.18.5 Meril Life Sciences Recent Development
11.19 Peijia Medical
11.19.1 Peijia Medical Company Detail
11.19.2 Peijia Medical Business Overview
11.19.3 Peijia Medical Blood Vessels Embolic Agents Introduction
11.19.4 Peijia Medical Revenue in Blood Vessels Embolic Agents Business (2019-2024)
11.19.5 Peijia Medical Recent Development
11.20 Wallaby Medical
11.20.1 Wallaby Medical Company Detail
11.20.2 Wallaby Medical Business Overview
11.20.3 Wallaby Medical Blood Vessels Embolic Agents Introduction
11.20.4 Wallaby Medical Revenue in Blood Vessels Embolic Agents Business (2019-2024)
11.20.5 Wallaby Medical Recent Development
11.21 MicroPort Scientific Corporation
11.21.1 MicroPort Scientific Corporation Company Detail
11.21.2 MicroPort Scientific Corporation Business Overview
11.21.3 MicroPort Scientific Corporation Blood Vessels Embolic Agents Introduction
11.21.4 MicroPort Scientific Corporation Revenue in Blood Vessels Embolic Agents Business (2019-2024)
11.21.5 MicroPort Scientific Corporation Recent Development
11.22 Weihai Visee Medical Devices
11.22.1 Weihai Visee Medical Devices Company Detail
11.22.2 Weihai Visee Medical Devices Business Overview
11.22.3 Weihai Visee Medical Devices Blood Vessels Embolic Agents Introduction
11.22.4 Weihai Visee Medical Devices Revenue in Blood Vessels Embolic Agents Business (2019-2024)
11.22.5 Weihai Visee Medical Devices Recent Development
11.23 Beijing Taijieweiye Technology
11.23.1 Beijing Taijieweiye Technology Company Detail
11.23.2 Beijing Taijieweiye Technology Business Overview
11.23.3 Beijing Taijieweiye Technology Blood Vessels Embolic Agents Introduction
11.23.4 Beijing Taijieweiye Technology Revenue in Blood Vessels Embolic Agents Business (2019-2024)
11.23.5 Beijing Taijieweiye Technology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Blood Vessels Embolic Agents Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Microsphere
Table 3. Key Players of Liquid Embolics Agents
Table 4. Key Players of Embolic Coils
Table 5. Key Players of Embolic Plug Systems
Table 6. Key Players of Detachable Balloons
Table 7. Key Players of Others
Table 8. Global Blood Vessels Embolic Agents Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Blood Vessels Embolic Agents Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Blood Vessels Embolic Agents Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global Blood Vessels Embolic Agents Market Share by Region (2019-2024)
Table 12. Global Blood Vessels Embolic Agents Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global Blood Vessels Embolic Agents Market Share by Region (2025-2030)
Table 14. Blood Vessels Embolic Agents Market Trends
Table 15. Blood Vessels Embolic Agents Market Drivers
Table 16. Blood Vessels Embolic Agents Market Challenges
Table 17. Blood Vessels Embolic Agents Market Restraints
Table 18. Global Blood Vessels Embolic Agents Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global Blood Vessels Embolic Agents Market Share by Players (2019-2024)
Table 20. Global Top Blood Vessels Embolic Agents Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Vessels Embolic Agents as of 2023)
Table 21. Ranking of Global Top Blood Vessels Embolic Agents Companies by Revenue (US$ Million) in 2023
Table 22. Global 5 Largest Players Market Share by Blood Vessels Embolic Agents Revenue (CR5 and HHI) & (2019-2024)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Blood Vessels Embolic Agents Product Solution and Service
Table 25. Date of Enter into Blood Vessels Embolic Agents Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Blood Vessels Embolic Agents Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global Blood Vessels Embolic Agents Revenue Market Share by Type (2019-2024)
Table 29. Global Blood Vessels Embolic Agents Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global Blood Vessels Embolic Agents Revenue Market Share by Type (2025-2030)
Table 31. Global Blood Vessels Embolic Agents Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global Blood Vessels Embolic Agents Revenue Market Share by Application (2019-2024)
Table 33. Global Blood Vessels Embolic Agents Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global Blood Vessels Embolic Agents Revenue Market Share by Application (2025-2030)
Table 35. North America Blood Vessels Embolic Agents Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Blood Vessels Embolic Agents Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Blood Vessels Embolic Agents Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Blood Vessels Embolic Agents Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Europe Blood Vessels Embolic Agents Market Size by Country (2019-2024) & (US$ Million)
Table 40. Europe Blood Vessels Embolic Agents Market Size by Country (2025-2030) & (US$ Million)
Table 41. Asia-Pacific Blood Vessels Embolic Agents Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 42. Asia-Pacific Blood Vessels Embolic Agents Market Size by Region (2019-2024) & (US$ Million)
Table 43. Asia-Pacific Blood Vessels Embolic Agents Market Size by Region (2025-2030) & (US$ Million)
Table 44. Latin America Blood Vessels Embolic Agents Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Latin America Blood Vessels Embolic Agents Market Size by Country (2019-2024) & (US$ Million)
Table 46. Latin America Blood Vessels Embolic Agents Market Size by Country (2025-2030) & (US$ Million)
Table 47. Middle East & Africa Blood Vessels Embolic Agents Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Middle East & Africa Blood Vessels Embolic Agents Market Size by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Blood Vessels Embolic Agents Market Size by Country (2025-2030) & (US$ Million)
Table 50. Abbott Company Detail
Table 51. Abbott Business Overview
Table 52. Abbott Blood Vessels Embolic Agents Product
Table 53. Abbott Revenue in Blood Vessels Embolic Agents Business (2019-2024) & (US$ Million)
Table 54. Abbott Recent Development
Table 55. Boston Scientific Corporation Company Detail
Table 56. Boston Scientific Corporation Business Overview
Table 57. Boston Scientific Corporation Blood Vessels Embolic Agents Product
Table 58. Boston Scientific Corporation Revenue in Blood Vessels Embolic Agents Business (2019-2024) & (US$ Million)
Table 59. Boston Scientific Corporation Recent Development
Table 60. Cook Medical LLC Company Detail
Table 61. Cook Medical LLC Business Overview
Table 62. Cook Medical LLC Blood Vessels Embolic Agents Product
Table 63. Cook Medical LLC Revenue in Blood Vessels Embolic Agents Business (2019-2024) & (US$ Million)
Table 64. Cook Medical LLC Recent Development
Table 65. Johnson & Johnson Company Detail
Table 66. Johnson & Johnson Business Overview
Table 67. Johnson & Johnson Blood Vessels Embolic Agents Product
Table 68. Johnson & Johnson Revenue in Blood Vessels Embolic Agents Business (2019-2024) & (US$ Million)
Table 69. Johnson & Johnson Recent Development
Table 70. Medtronic Company Detail
Table 71. Medtronic Business Overview
Table 72. Medtronic Blood Vessels Embolic Agents Product
Table 73. Medtronic Revenue in Blood Vessels Embolic Agents Business (2019-2024) & (US$ Million)
Table 74. Medtronic Recent Development
Table 75. Acandis GmbH Company Detail
Table 76. Acandis GmbH Business Overview
Table 77. Acandis GmbH Blood Vessels Embolic Agents Product
Table 78. Acandis GmbH Revenue in Blood Vessels Embolic Agents Business (2019-2024) & (US$ Million)
Table 79. Acandis GmbH Recent Development
Table 80. SSEM Mthembu Medical (Pty) Ltd Company Detail
Table 81. SSEM Mthembu Medical (Pty) Ltd Business Overview
Table 82. SSEM Mthembu Medical (Pty) Ltd Blood Vessels Embolic Agents Product
Table 83. SSEM Mthembu Medical (Pty) Ltd Revenue in Blood Vessels Embolic Agents Business (2019-2024) & (US$ Million)
Table 84. SSEM Mthembu Medical (Pty) Ltd Recent Development
Table 85. Balt USA LLC Company Detail
Table 86. Balt USA LLC Business Overview
Table 87. Balt USA LLC Blood Vessels Embolic Agents Product
Table 88. Balt USA LLC Revenue in Blood Vessels Embolic Agents Business (2019-2024) & (US$ Million)
Table 89. Balt USA LLC Recent Development
Table 90. Stryker Company Detail
Table 91. Stryker Business Overview
Table 92. Stryker Blood Vessels Embolic Agents Product
Table 93. Stryker Revenue in Blood Vessels Embolic Agents Business (2019-2024) & (US$ Million)
Table 94. Stryker Recent Development
Table 95. Guerbet LLC Company Detail
Table 96. Guerbet LLC Business Overview
Table 97. Guerbet LLC Blood Vessels Embolic Agents Product
Table 98. Guerbet LLC Revenue in Blood Vessels Embolic Agents Business (2019-2024) & (US$ Million)
Table 99. Guerbet LLC Recent Development
Table 100. Terumo Corporation Company Detail
Table 101. Terumo Corporation Business Overview
Table 102. Terumo Corporation Blood Vessels Embolic Agents Product
Table 103. Terumo Corporation Revenue in Blood Vessels Embolic Agents Business (2019-2024) & (US$ Million)
Table 104. Terumo Corporation Recent Development
Table 105. Penumbra Company Detail
Table 106. Penumbra Business Overview
Table 107. Penumbra Blood Vessels Embolic Agents Product
Table 108. Penumbra Revenue in Blood Vessels Embolic Agents Business (2019-2024) & (US$ Million)
Table 109. Penumbra Recent Development
Table 110. Grandpharma (Sirtex) Company Detail
Table 111. Grandpharma (Sirtex) Business Overview
Table 112. Grandpharma (Sirtex) Blood Vessels Embolic Agents Product
Table 113. Grandpharma (Sirtex) Revenue in Blood Vessels Embolic Agents Business (2019-2024) & (US$ Million)
Table 114. Grandpharma (Sirtex) Recent Development
Table 115. Merit Medical Company Detail
Table 116. Merit Medical Business Overview
Table 117. Merit Medical Blood Vessels Embolic Agents Product
Table 118. Merit Medical Revenue in Blood Vessels Embolic Agents Business (2019-2024) & (US$ Million)
Table 119. Merit Medical Recent Development
Table 120. Siemens Healthineers (Varian) Company Detail
Table 121. Siemens Healthineers (Varian) Business Overview
Table 122. Siemens Healthineers (Varian) Blood Vessels Embolic Agents Product
Table 123. Siemens Healthineers (Varian) Revenue in Blood Vessels Embolic Agents Business (2019-2024) & (US$ Million)
Table 124. Siemens Healthineers (Varian) Recent Development
Table 125. Jiangsu Hengrui Medicine Company Detail
Table 126. Jiangsu Hengrui Medicine Business Overview
Table 127. Jiangsu Hengrui Medicine Blood Vessels Embolic Agents Product
Table 128. Jiangsu Hengrui Medicine Revenue in Blood Vessels Embolic Agents Business (2019-2024) & (US$ Million)
Table 129. Jiangsu Hengrui Medicine Recent Development
Table 130. Kaneka Company Detail
Table 131. Kaneka Business Overview
Table 132. Kaneka Blood Vessels Embolic Agents Product
Table 133. Kaneka Revenue in Blood Vessels Embolic Agents Business (2019-2024) & (US$ Million)
Table 134. Kaneka Recent Development
Table 135. Meril Life Sciences Company Detail
Table 136. Meril Life Sciences Business Overview
Table 137. Meril Life Sciences Blood Vessels Embolic Agents Product
Table 138. Meril Life Sciences Revenue in Blood Vessels Embolic Agents Business (2019-2024) & (US$ Million)
Table 139. Meril Life Sciences Recent Development
Table 140. Peijia Medical Company Detail
Table 141. Peijia Medical Business Overview
Table 142. Peijia Medical Blood Vessels Embolic Agents Product
Table 143. Peijia Medical Revenue in Blood Vessels Embolic Agents Business (2019-2024) & (US$ Million)
Table 144. Peijia Medical Recent Development
Table 145. Wallaby Medical Company Detail
Table 146. Wallaby Medical Business Overview
Table 147. Wallaby Medical Blood Vessels Embolic Agents Product
Table 148. Wallaby Medical Revenue in Blood Vessels Embolic Agents Business (2019-2024) & (US$ Million)
Table 149. Wallaby Medical Recent Development
Table 150. MicroPort Scientific Corporation Company Detail
Table 151. MicroPort Scientific Corporation Business Overview
Table 152. MicroPort Scientific Corporation Blood Vessels Embolic Agents Product
Table 153. MicroPort Scientific Corporation Revenue in Blood Vessels Embolic Agents Business (2019-2024) & (US$ Million)
Table 154. MicroPort Scientific Corporation Recent Development
Table 155. Weihai Visee Medical Devices Company Detail
Table 156. Weihai Visee Medical Devices Business Overview
Table 157. Weihai Visee Medical Devices Blood Vessels Embolic Agents Product
Table 158. Weihai Visee Medical Devices Revenue in Blood Vessels Embolic Agents Business (2019-2024) & (US$ Million)
Table 159. Weihai Visee Medical Devices Recent Development
Table 160. Beijing Taijieweiye Technology Company Detail
Table 161. Beijing Taijieweiye Technology Business Overview
Table 162. Beijing Taijieweiye Technology Blood Vessels Embolic Agents Product
Table 163. Beijing Taijieweiye Technology Revenue in Blood Vessels Embolic Agents Business (2019-2024) & (US$ Million)
Table 164. Beijing Taijieweiye Technology Recent Development
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Blood Vessels Embolic Agents Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Blood Vessels Embolic Agents Market Share by Type: 2023 VS 2030
Figure 3. Microsphere Features
Figure 4. Liquid Embolics Agents Features
Figure 5. Embolic Coils Features
Figure 6. Embolic Plug Systems Features
Figure 7. Detachable Balloons Features
Figure 8. Others Features
Figure 9. Global Blood Vessels Embolic Agents Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Blood Vessels Embolic Agents Market Share by Application: 2023 VS 2030
Figure 11. Hospital & Clinic Case Studies
Figure 12. Ambulatory Surgical Center Case Studies
Figure 13. Others Case Studies
Figure 14. Blood Vessels Embolic Agents Report Years Considered
Figure 15. Global Blood Vessels Embolic Agents Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Blood Vessels Embolic Agents Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Blood Vessels Embolic Agents Market Share by Region: 2023 VS 2030
Figure 18. Global Blood Vessels Embolic Agents Market Share by Players in 2023
Figure 19. Global Top Blood Vessels Embolic Agents Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Vessels Embolic Agents as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Blood Vessels Embolic Agents Revenue in 2023
Figure 21. North America Blood Vessels Embolic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Blood Vessels Embolic Agents Market Share by Country (2019-2030)
Figure 23. United States Blood Vessels Embolic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Blood Vessels Embolic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Blood Vessels Embolic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Blood Vessels Embolic Agents Market Share by Country (2019-2030)
Figure 27. Germany Blood Vessels Embolic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Blood Vessels Embolic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Blood Vessels Embolic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Blood Vessels Embolic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Blood Vessels Embolic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Blood Vessels Embolic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Blood Vessels Embolic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Blood Vessels Embolic Agents Market Share by Region (2019-2030)
Figure 35. China Blood Vessels Embolic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Blood Vessels Embolic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Blood Vessels Embolic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Blood Vessels Embolic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Blood Vessels Embolic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Blood Vessels Embolic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Blood Vessels Embolic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Blood Vessels Embolic Agents Market Share by Country (2019-2030)
Figure 43. Mexico Blood Vessels Embolic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Blood Vessels Embolic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Blood Vessels Embolic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Blood Vessels Embolic Agents Market Share by Country (2019-2030)
Figure 47. Turkey Blood Vessels Embolic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Blood Vessels Embolic Agents Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Abbott Revenue Growth Rate in Blood Vessels Embolic Agents Business (2019-2024)
Figure 50. Boston Scientific Corporation Revenue Growth Rate in Blood Vessels Embolic Agents Business (2019-2024)
Figure 51. Cook Medical LLC Revenue Growth Rate in Blood Vessels Embolic Agents Business (2019-2024)
Figure 52. Johnson & Johnson Revenue Growth Rate in Blood Vessels Embolic Agents Business (2019-2024)
Figure 53. Medtronic Revenue Growth Rate in Blood Vessels Embolic Agents Business (2019-2024)
Figure 54. Acandis GmbH Revenue Growth Rate in Blood Vessels Embolic Agents Business (2019-2024)
Figure 55. SSEM Mthembu Medical (Pty) Ltd Revenue Growth Rate in Blood Vessels Embolic Agents Business (2019-2024)
Figure 56. Balt USA LLC Revenue Growth Rate in Blood Vessels Embolic Agents Business (2019-2024)
Figure 57. Stryker Revenue Growth Rate in Blood Vessels Embolic Agents Business (2019-2024)
Figure 58. Guerbet LLC Revenue Growth Rate in Blood Vessels Embolic Agents Business (2019-2024)
Figure 59. Terumo Corporation Revenue Growth Rate in Blood Vessels Embolic Agents Business (2019-2024)
Figure 60. Penumbra Revenue Growth Rate in Blood Vessels Embolic Agents Business (2019-2024)
Figure 61. Grandpharma (Sirtex) Revenue Growth Rate in Blood Vessels Embolic Agents Business (2019-2024)
Figure 62. Merit Medical Revenue Growth Rate in Blood Vessels Embolic Agents Business (2019-2024)
Figure 63. Siemens Healthineers (Varian) Revenue Growth Rate in Blood Vessels Embolic Agents Business (2019-2024)
Figure 64. Jiangsu Hengrui Medicine Revenue Growth Rate in Blood Vessels Embolic Agents Business (2019-2024)
Figure 65. Kaneka Revenue Growth Rate in Blood Vessels Embolic Agents Business (2019-2024)
Figure 66. Meril Life Sciences Revenue Growth Rate in Blood Vessels Embolic Agents Business (2019-2024)
Figure 67. Peijia Medical Revenue Growth Rate in Blood Vessels Embolic Agents Business (2019-2024)
Figure 68. Wallaby Medical Revenue Growth Rate in Blood Vessels Embolic Agents Business (2019-2024)
Figure 69. MicroPort Scientific Corporation Revenue Growth Rate in Blood Vessels Embolic Agents Business (2019-2024)
Figure 70. Weihai Visee Medical Devices Revenue Growth Rate in Blood Vessels Embolic Agents Business (2019-2024)
Figure 71. Beijing Taijieweiye Technology Revenue Growth Rate in Blood Vessels Embolic Agents Business (2019-2024)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
